Mobile search icon
Eurofins Belgium NL >> Eurofins Biopharma Product Testing Belgium >> Pharmaceutical Chemistry

Pharmaceutical Chemistry Testing Belgium - Eurofins Scientific

Contact Us

Teams are dedicated to method development, transfer, verification and validation, ensuring optimisation of methods used for release and stability testing. We offer stability storage and testing across all typical ICH guidelines.

To support your commercial, stability product and clinical trial material release testing needs, Eurofins BioPharma Product Testing offers the capacity and breadth of capabilities to test your drug substance, drug product or in-process materials in a timely manner.

We test materials against specification for identity, potency, impurities, and physical properties under strict cGMP compliance, and we customise individual programmes to streamline lab documentation and reporting for the most efficient and quality-focused data deliverable possible.

Our multi-shift laboratory operations are designed to provide extensive capacity for larger volume release programmes, as well as flexibility for smaller programs in a manner that allows for aggressive cycle times. We have experience working with every type of modality and have the flexibility and extensive instrument capacity within our team to meet the ever-changing demands of production schedules and timelines.

  • Drug product analysis (tablets, capsules, patches, powders, liquids, etc)
  • Development, transfer, validation, verification
  • Release testing, marketed product, clinical studies, stability testing, R&D, comparators
  • Appearance/identification
  • Assay/potency/content uniformity
  • Product specific testing
  • Unknown identification by LC/MS

 

  • Impurity analysis (process impurities, degradants, related substances)
  • Dissolution (USP 1, 2, 5) and disintegration testing
  • Water content (volumetric, coulometric, oven)
  • Particle size analysis (Mastersizer, Zetasizer)
  • Residual impurities analysis by LC/MS Q-TOF
  • Cleaning verification method development, validation, and testing

No bio/pharmaceutical product can be manufactured without first establishing the identity, purity and quality of its starting materials to ensure the product is suitable for its intended use. When this critical step in the bio/pharmaceutical manufacturing process is performed successfully, costly production problems and delays can be avoided.

Eurofins BioPharma Product Testing has the wide range of chemistry expertise and state-of-the-art instruments required to perform all types of raw materials testing, including qualification of compendial methods, as well as development, qualification and validation of new methods.

Whether you are looking for assistance in the release of your raw materials for production purposes or in the qualification of your vendors, we can help keep your project on track. All of our testing is performed in accordance with EP, USP/NF, BP and JP methodologies and monographs, in addition to any client-supplied or vendor-defined methods.

Our extensive testing experience, coupled with expertise in scientific problem solving and compendial consultation, allows us to successfully meet your testing challenges and help you prevent costly production problems and delays.

  • Complete compendia analysis (USP, EP, JP, CP, BP, ACS)
  • Residual solvents EP 2.4.24 and USP <467>
  • Raw materials, excipients, and API testing
  • Method establishment: development, feasibility, transfer, verification, qualification, and validation
  • Method types include compendia and client specific, customised to product specifications and requirements
  • Release testing supporting client QC and manufacturing, streamlined to provide consistent high quality on-time delivery for established test methods
  • Testing includes: AA/GFAA, HPLC/UPLC, GC, GC/MS, TLC, TOC,  Autotitration, LOD, Turbidity,  Conductivity, Osmolality, UV, Melting point, Polarimetry, Viscosity, FTIR, ROI, KF
  • Product specific testing

Efficient & Effective Approaches to managing Raw material methods

Learn about strategies for ensuring compliance for Excipient and API method establishment—keys to success in today's regulatory environment.

Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities

Learn about challenges presented by residuals in biopharmaceutical manufacturing, as well as analytical approaches for cell- and process-associated residuals, strategies for using a platform method technology and how to deal with matrix effect.

If you’re interested in working with Eurofins on a Biopharma project, fill out the form below and a member of our Team will be in contact to discuss your project.

Vul dit veld in. Maximum character limit is 30.
Vul dit veld in. Maximum character limit is 30.
Vul dit veld in.
Vul dit veld in.
Vul dit veld in. Maximum character limit is 30.
Vul dit veld in. Enter valid Phone Number with format (Country Code-Phone Number) Phone number cannot exceed more than 20 digits.
Vul dit veld in. Voer een geldig e-mailadres in.
Vul dit veld in. Maximaal toegestane tekens is 5000.
Toegestane bestandsgrootte voor uploaden is 2 MB. Toegestane bestandstypen: doc, docx & pdf.
Please accept the privacy policy .

Please fill Captcha
Er is iets fout gegaan. Probeer het later opnieuw. Ongeldige tekst in de velden.
Thank you for your enquiry